Disease modification for hidradenitis suppurativa: A new paradigm - 18/04/17
Plan
Funding sources: None. |
|
Dr Hamzavi is an investigator for and has received funding from AbbVie and The Microdermis Corporation and is President of the Hidradenitis Suppurativa Foundation. Dr Paek is an investigator and consultant for AbbVie and Novartis. Dr Qureshi is a consultant for Eli Lilly, Novartis, Abbvie, Janssen, Pfizer, and the Centers for Disease Control and Prevention and has received licenses for a Psoriatic Arthritis Screening and Evaluation tool and psoriasis severity indices. Dr Danby has no conflicts of interest to declare. |
Vol 76 - N° 4
P. 772-773 - avril 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?